IMPAQ conducted randomized controlled trial (RCT) impact evaluations to examine the effects of interventions aimed at combating child labor in Costa Rica, Ecuador, India, Malawi, and Rwanda. (IMPAQ was acquired by AIR in 2020.)
This research brief shares findings related to participants’ awareness of xenotransplantation as a potential future kidney transplant option in light of recent advancements. We also discuss what the participants perceived as the benefits and risks of xenotransplantation as well as their recommendations for when and how patients, families, and clinicians ...